Pure Health Holding Pjsc · ADX:PUREHEALTH
Pure Health Holding Pjsc — PureHealth — H1 2026 Earnings Presentation
44 slides from Pure Health Holding Pjsc's earnings presentation, August 2026
Slide 1: H1 2026 Earnings Presentation
SEHA Kidney Care – Central, Abu Dhabi H1 2026 Earnings Presentation August 2026
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by PureHealth (the “Company”) for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investment activity, nor does it
Slide 3: Contents
Sheikh Shakhbout Medical City, Abu Dhabi Contents Performance Highlights 4 Operational & Strategic Highlights 6 Segment Review 16 Financial Review 26 Outlook & Guidance 33 Appendix 35
Slide 4: A Transformation Leader Across Healthcare and Insurance
H1 2026 Earnings Presentation A Transformation Leader Across Healthcare and Insurance Expanding our Footprint, Deepening our Market Leadership UAE’s Largest UK’s Largest Largest Private Healthcare UAE’s Largest Healthcare Group Private Healthcare Group Group in Greece & Cyprus Health Insurer Circle
Slide 5: H1 2026 Performance Highlights
H1 2026 Earnings Presentation H1 2026 Performance Highlights Broad-based growth and strong profitability across the Group supported by an increasingly diversified earnings base. Group Financial Results (YoY) Care (Healthcare) Cover (Insurance) Hospitals Diagnostics Procurement Technology Health Insu
Slide 6: Operational & Strategic Highlights
Sheikh Shakhbout Medical City, Abu Dhabi Operational & Strategic Highlights
Slide 7: H1 2026 Key Operational Highlights
H1 2026 Earnings Presentation H1 2026 Key Operational Highlights Driving strategic growth and value creation through transformation, operational efficiency, technology enablement and synergy delivery. Care (Healthcare) Clinical Capability Expansion and Cyprus Bolt-On Acquisition Leading High-Acuity
Slide 8: H1 2026 Key Operational Highlights
H1 2026 Earnings Presentation H1 2026 Key Operational Highlights Driving strategic growth and value creation through transformation, operational efficiency, technology enablement and synergy delivery. Care (Healthcare) Cover (Insurance) Enhancing Care Offerings and Achieving Advancing Clinical Techn
Slide 9: Demonstrating World-Class Clinical Excellence
H1 2026 Earnings Presentation Demonstrating World-Class Clinical Excellence Showcased clinical expertise through the successful separation of conjoined twins. GCC’s First Separation of craniopagus twins joined at the top of the head 4 Complex surgical procedures SKMC Successfully Performs Landmark C
Slide 10: PureHealth and Aldar Partner to Develop Longevity Focused Communities
H1 2026 Earnings Presentation PureHealth and Aldar Partner to Develop Longevity Focused Communities Aldar – Longevity-Focused Community Diversify group revenues through entering real estate development. • Strategic partnership to integrate healthcare, preventive wellness and community design across
Slide 11: Universities as a Strategic Engine for Driving Long-Term Growth
H1 2026 Earnings Presentation Universities as a Strategic Engine for Driving Long-Term Growth Investing in medical education and physician development to build a sustainable healthcare talent pipeline, which will serve as feeder system for PureHealth European and UK platform. Launch of University of
Slide 12: Development of AI and Digital Platforms Across the Group
H1 2026 Earnings Presentation Development of AI and Digital Platforms Across the Group Focus on AI and digital capabilities across the Group to enhance clinical outcomes, operations and customer engagement Strong AI Foundation • AI Factory: An on-premise platform enabling development, deployment and
Slide 13: Advancing Research at a National Scale
H1 2026 Earnings Presentation Advancing Research at a National Scale Scaled, accredited, and innovation-driven research platform powering PureHealth’s long-term value creation Research Highlights H1 2026 Collaborations include 14 of the top 15 global biopharma companies #1 Innovative Research Capabi
Slide 14: International Strategy Delivering Scale, Diversification and Returns
H1 2026 Earnings Presentation International Strategy Delivering Scale, Diversification and Returns Disciplined buy-and-build execution is strengthening PureHealth’s international platform, supporting resilient and profitable growth Our Strategic Approach Diversified, Resilient Footprint with High Re
Slide 15: Scaling Insurance Market Share with Disciplined Underwriting
H1 2026 Earnings Presentation Scaling Insurance Market Share with Disciplined Underwriting Daman is prioritising scale, retention and multi-line growth, with targeted investment supporting long-term platform value Defend & win share Broaden the platform Invest for scale Compound value Renewals, targ
Slide 16: Segment Review
Daman Headquarters, Abu Dhabi Segment Review
Slide 17: Care: Broad-Based Volume Growth
H1 2026 Earnings Presentation Care: Broad-Based Volume Growth Healthcare Outpatient Volumes Inpatient Volumes (in Thousands) (in Thousands) +50% +51% 163 108 83 +23% 55 5,443 4,440 Q2 2025 Q2 2026 H1 2025 H1 2026 +26% Radiology Volumes1 2,853 (in Thousands) 2,269 +59% +33% 1,387 1,042 849 536 Q2 202
Slide 18: UAE Care: Heightened Patient Activity Supported by Strong Execution
H1 2026 Earnings Presentation UAE Care: Heightened Patient Activity Supported by Strong Execution Patient activity grew in Q2, with outpatient growth accelerating and inpatient momentum sustained as utilisation ramps up +12% Outpatient Volumes +3% 1,978 (in Thousands) 1,773 1,640 1,682 2025 2026 Q1
Slide 19: UAE Care: Resilient Volume Growth and Accelerated Recovery
H1 2026 Earnings Presentation UAE Care: Resilient Volume Growth and Accelerated Recovery Healthcare Outpatient Volumes UAE Prescriptions Dispensed (in Thousands) (in Thousands) +10% +7% 3,660 1,607 3,413 1,456 +12% +15% 852 1,978 1,773 743 Q2 2025 Q2 2026 H1 2025 H1 2026 Q2 2025 Q2 2026 H1 2025 H1 2
Slide 20: UAE Care: Robust Growth Across Key Metrics
H1 2026 Earnings Presentation UAE Care: Robust Growth Across Key Metrics Healthcare Note: Reduction in lab volumes reflects lower UAE Radiology Volumes UAE Lab Volumes visa screening activity and volumes from (in Thousands) (in Millions) assets operating under capitation model +9% -4% 753 16.7 16.0
Slide 21: UAE Care: Strong Profitability Recovery Despite Reported Revenue Headwinds
H1 2026 Earnings Presentation UAE Care: Strong Profitability Recovery Despite Reported Revenue Headwinds Healthcare Revenue and Normalised Revenue (in AED Mn) Commentary • Reported UAE Care revenue declined 13% YoY in 6,973 6,641 +5% H1’26, primarily reflecting the impact of Unified -13% Procurement
Slide 22: UAE Care: Consistent Inpatient Capacity Expansion Across Abu Dhabi
H1 2026 Earnings Presentation UAE Care: Consistent Inpatient Capacity Expansion Across Abu Dhabi Healthcare Inpatient Operational Bed Capacity & Occupancy 3,300 75.1% 77.5% 76.2% 80% +9.2 pp 3,100 67.0% 2,975 70% FY’23-H1’26 2,900 2,827 2,700 2,624 2,655 60% 2,500 50% 2,300 2,100 +4.3% 40% 1,900 CAG
Slide 23: International Care: Scaling with Strong Margins and Underlying Momentum
H1 2026 Earnings Presentation International Care: Scaling with Strong Margins and Underlying Momentum Healthcare Total Patient Interactions1 Revenue (in Thousands) 1,863 (in AED Mn) 4,954 +76% +56% +79% +52% 3,177 914 1,059 2,451 512 1,608 Q2 2025 Q2 2026 H1 2025 H1 2026 Q2 2025 Q2 2026 H1 2025 H1 2
Slide 24: International Care: Circle Turnaround Shifting to Profitable, Higher-Acuity Care
H1 2026 Earnings Presentation International Care: Circle Turnaround Shifting to Profitable, Higher-Acuity Care Healthcare Revenue (in AED Mn) +9% +8% 6,458 6,006 5,505 3,379 FY 2023 FY 2024 FY 2025 H1 2026 Net Profit (in AED Mn) +214% 166 127 Impact of UK budgetary changes on National 122 99 Insuran
Slide 25: Cover: Resilient Performance
H1 2026 Earnings Presentation Cover: Resilient Performance Insurance Gross Written Premium Claims Processed Members Insured (in AED Bn) (in Millions) (in Millions) +13% 5.5 +5% 28.3 27.0 4.9 +4% 3.4 3.3 H1 2025 H1 2026 H1 2025 H1 2026 Solvency Ratio % Investment Income (in AED Mn) 189% 151 -8% 171%
Slide 26: Financial Review
PureLab Central Reference Lab, Abu Dhabi Financial Review
Slide 27: Group: Strong Earnings Growth and Margin Expansion
H1 2026 Earnings Presentation Group: Strong Earnings Growth and Margin Expansion Commentary AED Mn Q2 2025 Q2 2026 Δ% H1 2025 H1 2026 Δ% • Group revenue increased 9.4% YoY in H1’26, supported by HHG consolidation (AED 1.6bn) and continued momentum in Cover and International Care. Revenue 6,993 7,588
Slide 28: Care: International Scale and UAE Recovery Drive Strong Margin Expansion
H1 2026 Earnings Presentation Care: International Scale and UAE Recovery Drive Strong Margin Expansion Healthcare Commentary AED Mn Q2 2025 Q2 2026 Δ% H1 2025 H1 2026 Δ% • Care revenue increased 9.2% YoY in H1’26, supported primarily by HHG consolidation and continued growth across the international
Slide 29: Cover: Strong Revenue and Earnings Growth with Stable Margins
H1 2026 Earnings Presentation Cover: Strong Revenue and Earnings Growth with Stable Margins Insurance Commentary AED Mn Q2 2025 Q2 2026 Δ% H1 2025 H1 2026 Δ% • Cover revenue increased 9.9% YoY to AED 4.1bn in H1’26, supported by GWP growth of 13%, driven by strong renewals, disciplined pricing and c
Slide 30: Free Cash Flow Reflects Working Capital Seasonality and Continued Investment
H1 2026 Earnings Presentation Free Cash Flow Reflects Working Capital Seasonality and Continued Investment AED Mn H1 2025 H1 2026 Working Capital Changes H1 2026 EBITDA 2,319 2,874 (in AED Mn) 1 Change in Net Working Capital (2,699) (3,217) Inventories (225) Other operating activities 1,052 (36) Due
Slide 31: Strong Balance Sheet Supporting Growth and Capital Deployment
H1 2026 Earnings Presentation Strong Balance Sheet Supporting Growth and Capital Deployment Total Assets (AED Bn) Cash & Bank Balance (AED Bn) Net Debt / EBITDA Commentary • The Group maintains a solid financial position, with total assets of AED 57.2bn, and 57.2 4.7 sufficient liquidity to support
Slide 32: Balanced Approach to Capital Allocation Driving Long-Term Value Creation
H1 2026 Earnings Presentation Balanced Approach to Capital Allocation Driving Long-Term Value Creation Shareholder Returns Inorganic Growth 1 Disciplined Capital Return Policy Clear Strategy to Drive Value Accretive M&A Target annual cash payout of • Pursuing disciplined M&A and bolt-on acquisitions
Slide 33: Outlook & Guidance
Sheikh Tahnoon bin Mohammed Medical City, Al Ain Outlook & Guidance
Slide 34: Medium-Term Strategic and Financial Targets
H1 2026 Earnings Presentation Medium-Term Strategic and Financial Targets Medium-term targets remain unchanged, supported by resilient execution and confidence in the Group’s growth outlook 2 Revenue International Care: EBITDA CAPEX as % Net Debt Dividend 1 Growth Revenue Share Margin of Revenue / E
Slide 35: Appendix
Appendix
Slide 36: Overview of Our Integrated Portfolio of Healthcare Assets
H1 2026 Earnings Presentation Overview of Our Integrated Portfolio of Healthcare Assets Care (Healthcare) Cover (Insurance) Hospitals Diagnostics Procurement Technology Health and P&C 1 H1 2026 Segment Value & Contribution in % Revenue AED 11,296 Mn (60%) AED 580 Mn (3%) AED 2,560 Mn (13%) AED 415 M
Slide 37: Delivering Excellence in Complex and Specialized Care
H1 2026 Earnings Presentation Delivering Excellence in Complex and Specialized Care Placenta Accreta Surgical Program Transplants Corniche successfully performed 24 complex placenta accreta Performed 7 liver and 66 kidney transplants in 2026, bringing surgeries, demonstrating leadership in high-risk
Slide 38: Balance Sheet
H1 2026 Earnings Presentation Balance Sheet AED Mn FY 2025 H1 2026 Δ% Total Non-Current Assets 36,657 37,223 2% Right of use assets 12,671 12,123 -4% Intangible Assets 12,568 12,291 -2% Property & equipment 7,397 7,222 -2% Other non-current assets 4,020 5,587 39% Total Current Assets 20,021 19,964 0
Slide 39: Income Statement
H1 2026 Earnings Presentation Income Statement AED Mn Q2 2025 Q2 2026 Δ% H1 2025 H1 2026 Δ% Revenue 6,993 7,588 +8.5% 13,574 14,851 +9.4% Cost of sales (5,433) (5,648) +4.0% (10,266) (11,232) +9.4% Gross profit 1,560 1,940 +24.4% 3,308 3,619 +9.4% G&A expenses incl. selling & distribution (980) (1,0
Slide 40: Cash Flow Statement
H1 2026 Earnings Presentation Cash Flow Statement AED Mn Q2 2025 Q2 2026 Δ% H1 2025 H1 2026 Δ% Net Profit for the period before tax 614 945 54% 1,175 1,403 19% Non-cash Adjustments 562 670 19% 1,155 1,403 21% 1 Working Capital Changes 601 -229 -138% -2,699 -3,217 19% Employees’ end of service benefi
Slide 41: Expanding Capacity & Specialised Services to Provide High-Acuity Care
H1 2026 Earnings Presentation Expanding Capacity & Specialised Services to Provide High-Acuity Care Targeted investments across hospitals and clinics to meet demand and strengthen clinical depth 80+ Beds Added in Al Ain 10 New Outpatient Clinics Strengthening Women’s Launch of Cancer Institute at Re
Slide 42: Groundbreaking of SEHA New Corniche Hospital
H1 2026 Earnings Presentation Groundbreaking of SEHA New Corniche Hospital Scaling high-complexity women’s and children’s care aligned with Abu Dhabi’s long-term health priorities • SEHA’s New Corniche will be a major milestone in delivering Abu Dhabi’s first integrated women’s and children’s medica
Slide 43: Circle Health: Broad-Based Expansion Across Advanced Care Services
H1 2026 Earnings Presentation Circle Health: Broad-Based Expansion Across Advanced Care Services Multi-site rollout of high-acuity capacity, robotic surgery and advanced diagnostics Capacity Expansion Surgical & Robotic Technology Additions Diagnostics Capacity Additions • Clementine Churchill Hospi
Slide 44: Investor Relations
Investor Relations purehealth.ae/investor-relations ir@purehealth.ae